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Although somatic cell reprogramming to generate
inducible pluripotent stem cells (iPSCs) is associated
with profound epigenetic changes, the roles and
mechanisms of epigenetic factors in this process
remain poorly understood. Here, we identify Jmjd3
as a potent negative regulator of reprogramming.
Jmjd3-deficient MEFs produced significantly more
iPSC colonies than did wild-type cells, whereas
ectopic expression of Jmjd3 markedly inhibited
reprogramming. We show that the inhibitory effects
of Jmjd3 are produced through both histone deme-
thylase-dependent and -independent pathways. The
latter pathway involves Jmjd3 targeting of PHF20 for
ubiquitination and degradation via recruitment of an
E3 ligase, Trim26. Importantly, PHF20-deficient
MEFs could not be converted to fully reprogrammed
iPSCs, even with knockdown of Jmjd3, Ink4a, or p21,
indicating that PHF20 is required for reprogramming.
Our findings demonstrate, to the best of our knowl-
edge, a previously unrecognized role of Jmjd3 in
cellular reprogramming and provide molecular
insight into the mechanisms by which the Jmjd3-
PHF20 axis controls this process.
INTRODUCTION
Both human and mouse somatic cells can be reprogrammed to
a pluripotent embryonic stem cell (ESC)-like state, giving rise to
induced pluripotent stem cells (iPSCs) by the use of four key
transcription factors: Oct4, Sox2, Klf4, and c-Myc (Takahashi
et al., 2007b; Takahashi and Yamanaka, 2006; Yu et al., 2007).
Because of their similarity to ESCs in terms of gene expression
profile, epigenetics/genetic marks, and their ability to self-renew
and differentiate into many different cell types, iPSCs hold
great promise for human disease modeling, drug screening,and perhaps therapeutic applications (Robinton and Daley,
2012; Stadtfeld and Hochedlinger, 2010). Although somatic
cell reprogramming can be achieved by several strategies
(Hanna et al., 2009; Robinton and Daley, 2012; Stadtfeld and
Hochedlinger, 2010), its efficiency and the kinetics of iPSCgener-
ation are still suboptimal, suggesting the existence of substantial
genetic and epigenetic barriers during reprogramming.
Many factors, including cell proliferation and cycling, mesen-
chymal-to-epithelial transitions, epigenetic regulation of histone
modification, and DNA methylation, influence reprogramming
efficiency (Plath and Lowry, 2011; Stadtfeld and Hochedlinger,
2010). Transiently enforced expression of reprogramming
factors leads to separable events, beginning with mesen-
chymal-to-epithelial transitions associated with loss of the
somatic marker THY1, followed by the activation of embryonic
markers such as alkaline phosphatase (AP) and stage-specific
embryonic antigen 1 (SSEA1) (Li et al., 2010; Plath and Lowry,
2011). Induction and maintenance of endogenous pluripotency
genes such as Nanog and Oct4 require further epigenetic
reprogramming changes at the DNA methylation and histone
modification levels (Stadtfeld and Hochedlinger, 2010). Failure
to achieve these epigenetic changes in a timely manner can
lead to partially reprogrammed iPSCs.
Global analysis of euchromatin dynamics during the reprog-
ramming process has revealed orchestrated epigenetic changes
at the histone modification level (Gaspar-Maia et al., 2011;
Hemberger et al., 2009; Koche et al., 2011). Both ESCs and
iPSCs contain ‘‘bivalent domains,’’ where nucleosomes are
marked with trimethylation at histone3-lysine27 (H3K27me3)
and histone3-lysine4 (H3K4me3) (Gaspar-Maia et al., 2011).
Whereas the Polycomb group (PcG) complex mediates H3K27
methylation and inhibits gene expression (Margueron and
Reinberg, 2011), Jmjd3 and Utx mediate H3K27 demethylation
(Agger et al., 2007; Lan et al., 2007). Thus, given the importance
of epigenetic factors in defining cell lineages, it is reasonable to
suggest that some of these factors are required for efficient
somatic reprogramming, whereas others may function as nega-
tive regulators. Removal of such roadblocks to successful
reprogramming will require increased insight into the molecularCell 152, 1037–1050, February 28, 2013 ª2013 Elsevier Inc. 1037
Figure 1. Identification of Jmjd3 and Other
Key Epigenetic Factors that Regulate
Reprogramming
(A) Outline of generation of transgenic mice ex-
pressing rtTA, together with Oct4 (O), Sox2 (S), Klf4
(K), and Myc (M) (OSKM, 4F) under control of
a tetracycline-on promoter (Tet-O).
(B) Western blot analysis of 4F expression in
Tet-O-4F MEFs treated with or without Dox.
(C) AP-positive colonies were counted at day 12
after Dox treatment.
(D) Bright-field images of an iPSC colony derived
from Tet-O-4F MEFs.
(E–G) Staining of representative iPSC colonies with
antibodies against AP, SSEA1, and Nanog. Scale
bars in (D)–(G), 50 mm.
(H) Fold changes in number of AP-positive colonies
generated from Tet-O 4F MEFs transduced with
specific shRNA, compared with control shRNA. AP-
positive colonies were counted on day 14 after Dox
treatment.
(I) Fold changes in number of AP-positive colonies
generated from Tet-O-4F MEFs transduced with
Jmjd3 expression or empty vector. Ectopic
expression of Jmjd3 inhibits reprogramming. The
data in (H) and (I) are reported as the means ± SD
with indicated significance (*p < 0.05, **p < 0.01,
and ***p < 0.001 by Student’s t test).
See also Figure S1.mechanisms by which epigenetic factors control cell lineage
and, hence, the dynamic process of reprogramming. Here, we
report identification of Jmjd3 as a potent negative regulator of
somatic cell reprogramming in screening studies of a panel of
histone-modifying proteins. Knockdown or ablation of Jmjd3
enhanced the efficiency and kinetics of reprogramming, appar-
ently by dual mechanisms: (1) Jmjd3 partially inhibits iPSC
reprogramming by promoting cell senescence through upregu-
lation of p21 and Ink4a, and (2) Jmjd3 targets PHF20 (plant
homeodomain finger protein 20) for ubiquitination and proteaso-
mal degradation via the E3 ubiquitin ligase Trim26 in a demethy-
lase activity-independent manner. Knockdown or ablation of
PHF20 blocks the reactivation of endogenous Oct4 expression,
thus leading to partially reprogrammed cells. Our results impli-
cate the Jmjd3-PHF20 axis as a key pathway in somatic cell
reprogramming and provide insights into the molecular mecha-
nisms used by Jmjd3 to impede efficient reprogramming.
RESULTS
Identification of Jmjd3 as an Inhibitor of Reprogramming
To establish a simpler and inducible 4F-based method to
generate iPSCs, we created transgenic mice expressing tetracy-
cline (Tet)-O-inducible Oct4, Sox2, Klf4, and Myc transgenic1038 Cell 152, 1037–1050, February 28, 2013 ª2013 Elsevier Inc.mice carrying rtTA-M2 reverse tetracycline
transactivator (Figure 1A). Mouse embry-
onic fibroblasts (MEFs) were generated
from intercrossing transgenic mice (Fig-
ure S1A available online). As shown in Fig-
ure 1B, Oct4, Sox2, Klf4, and Myc proteinswere readily detected by immunoblot analysis after treatment
with Dox for 24 hr. These 4F-expressing MEFs (Tet-O-4F
MEFs) could be efficiently reprogrammed to generate iPSCs in
the presence of Dox (Figure 1C). Withdrawal of Dox before
or at day 8 markedly reduced AP+ colony formation, but with-
drawal at day 10 or later showed little or no effect on AP+ colony
number using three different types of MEFs (wild-type [WT],
Tet-O-4F, and Oct4-GFP) (Figures S1B–S1D). The fully reprog-
rammed iPSCs stained positively for AP, SSEA-1, and Nanog
(Figures 1D–1G), suggesting that Tet-O-4F MEF-based reprog-
ramming would provide a reliable system to screen for epige-
netic factors that either enhance or reduce the efficiency of
reprogramming.
We predicted that epigenetic factors play critical roles in reac-
tivating the expression of stem-cell-enriched genes, while shut-
ting down the expression of cell-lineage-specific differentiation
genes, thus greatly increasing the efficiency of 4F-mediated
reprogramming. To test this notion, we selected a panel of small
hairpin RNAs (shRNAs) with high knockdown efficiency (>70%)
against a subset of genes encoding histone methyltransferases
or demethylases based on PCR or western blot analysis (Figures
S1E and S1F and Tables S1 and S2). After three rounds of
screening, we found that knockdown of the H3K27 methyltrans-
ferase Ezh2 and many histone demethylase genes, including
Figure 2. Jmjd3 Ablation Enhances the Effi-
ciency and Kinetics of Reprogramming
(A) Establishment of Jmjd3 KO mice and Jmjd3-
deficient MEFs. PCR and immunoblot (IB) analyses
confirmed loss of Jmjd3 expression in Jmjd3-
deficient MEFs.
(B) AP-positive colonies were counted on day 14 of
4F-mediated reprogramming or on day 21 of
3F-mediated reprogramming of WT and Jmjd3-
deficient MEF cells.
(C) AP-positive colonies were counted on day 14 of
4F-mediated reprogramming after tamoxifen
treatment of Ezh2f/f:Cre-ESR1 MEFs.
(D) Schematic representation of the time of AP+
colony appearance during reprogramming.
(E) Bright-field image of a representative iPSC
colony generated from Jmjd3-deficient MEFs.
(F and G) Staining of representative iPSC colonies
with antibodies against AP, SSEA-1, and Nanog.
Scale bars, 50 mm.
(H and I) Photomicrograph and hematoxylin and
eosin staining (H&E) of teratomas generated from
immune-deficient mice harboring a Jmjd3-defi-
cient iPSC clone. Three layers of teratoma (ecto-
derm, mesoderm, and endoderm) are presented.
Scale bars, 100 mm.
(J) Jmjd3/ MEF-derived iPSCs were pluripotent
and contributed to chimeras after injection into
BALB/C host blastocysts as indicated by coat
color.
The data in (B) and (C) are reported as means ± SD
with indicated significance (*p < 0.05 and **p < 0.01
by Student’s t test).Fbxl10, Jarid1b, Jarid1d, Jarid2, Jmjd1a, Jmjd2c, andUtx, mark-
edly decreased reprogramming efficiency (Figure 1H), which is
consistent with recent findings for Utx and Fbxl10 (Mansour
et al., 2012; Wang et al., 2011). By contrast, knockdown of
Jmjd3markedly increased the efficiency of 4F-mediated reprog-
ramming, whereas its ectopic expression resulted in decreased
reprogramming efficiency (Figure 1I), suggesting that Jmjd3
functions as a barrier to somatic reprogramming. This unique
feature of Jmjd3 led to its selection for further study.
Jmjd3 Ablation Enhances the Efficiency and Kinetics
of Reprogramming
To further define the role of Jmjd3 in reprogramming, we gener-
ated Jmjd3 knockout (KO) mice by targeted deletion of exons
15–21 using a Cre-LoxP system (Figure 2A). Mice with global
deletion of Jmjd3 died shortly after birth due to lung dysfunction
(Q.L., H.Y.W., I. Chepelev, G. Wei, K. Zhao, and R.-F. Wang,
unpublished data). Expression of Jmjd3 was abrogated in
Jmjd3-deficient MEFs (Figure 2A). Consistent with results ob-
tained by Jmjd3 knockdown, 4F-reprogramming of Jmjd3-
deficienct MEFs produced significantly more iPSC colonies
than did WT MEFs (Figure 2B). Robust reprogramming wasCell 152, 1037–1050, Falso achieved with Jmjd3-deficient 3F-
transduced MEFs (Oct4, Sox2, and Klf4),
compared with WT MEFs (Figure 2B). By
contrast, Ezh2-deficient MEFs, whichwere generated by treating Ezh2
flox/flox:Cre-ESR MEFs with
tamoxifen, strikingly inhibited the efficiency of 4F-mediated
reprogramming of MEFs (Figure 2C), further confirming that
Ezh2 is necessary for reprogramming. More importantly, we
found that AP+ iPSC colonies appeared much earlier in Jmjd3-
deficient MEFs than in WT MEFs (Figure 2D). The iPSCs gener-
ated from Jmjd3-deficient MEFs showed characteristic ESC
morphology and expressed markers such as AP, SSEA-1, and
Nanog (Figures 2E–2G). They also formed teratomas comprising
all three embryonic germ layers (Figures 2H and 2I) and contrib-
uted to chimeras after injection into BALB/C host blastocysts
(Figure 2J). Taken together, these results suggest that loss of
Jmjd3 markedly enhances the efficiency and kinetics of iPSC
reprogramming.
Jmjd3 Inhibits Reprogramming by Modulating
Expression of the Ink4a/Arf Locus
We next asked how Jmjd3 ablation enhances reprogramming.
Jmjd3 is thought to increase the expression of Ink4a/Arf in
MEFs by modifying H3K27 methylation in the promoter region
of the Ink4a/Arf locus (Agger et al., 2009; Barradas et al.,
2009). Knockdown or deletion of Ink4a/Arf and p21 reducesebruary 28, 2013 ª2013 Elsevier Inc. 1039
Figure 3. Identification of Jmjd3 Targets
Responsible for Enhanced Reprogramming
(A) Western blot analysis of Ink4a, Arf, and p21 inWT
and Jmjd3-deficient MEFs at passage 4.
(B) Growth of WT versus Jmjd3-deficient MEFs.
(C) b-gal staining of WT versus Jmjd3-deficient
MEFs at passage 4.
(D) Number of AP-positive iPSC colonies counted
on day 14 of 4F-mediated reprogramming of WT
MEFs transduced with Jmjd3-, Ink4a/Arf-, p21-
specific shRNAs, or control shRNAs.
(E) Jmjd3-deficient MEFs transduced with lentivi-
ruses expressing Jmjd3 or its mutants together with
4F for 3 days. Expression of Ink4a/Arf was deter-
mined by real-time PCR analysis and was normal-
ized by internal control b-actin.
(F) Number of AP-positive iPSC colonies counted on
day 11 of 4F-mediated reprogramming of Jmjd3-
deficient MEFs transduced with lentiviruses ex-
pressing Jmjd3 or its mutants.
(G) Western blot analysis of seven epigenetic
proteins in WT and Jmjd3-deficient MEFs, iPSCs,
and ES cells.
(H)Western blot analysis of PHF20 expression inWT
and Jmjd3-deficient MEFs during 4F-mediated
reprogramming.
The data in (B) and (D)–(F) are reported as means ±
SD with indicated significance (*p < 0.05, **p < 0.01,
and ***p < 0.001). See also Figures S2 and S3.cell senescence and markedly increases the efficiency of
reprogramming (Hong et al., 2009; Kawamura et al., 2009; Li
et al., 2009; Mario´n et al., 2009; Utikal et al., 2009). To assess
the expression level of these molecules in Jmjd3-deficient
MEFs, we showed that Jmjd3 deletion markedly reduced the
expression of Ink4a/Arf mRNA and protein (Figures 3A and
S2A). The p21 protein, but not its mRNA, was also reduced in
Jmjd3-deficient MEFs (Figures 3A and S2A). Consistent with
this, we found that Jmjd3-deficient MEF cells grew faster than
WT cells and had reduced cellular senescence based on
b-galactosidase (b-gal) staining, as compared with WT MEFs
(Figures 3B and 3C). Because the Jmjd3-deficient MEFs eventu-
ally underwent a senescence crisis after 5–7 passages, it is likely
that transient effects of Jmjd3 deficiency on cell proliferation and
senescence may have contributed to the improved efficiency
and kinetics of reprogramming.1040 Cell 152, 1037–1050, February 28, 2013 ª2013 Elsevier Inc.To determine the relative contribution of
downregulation of Ink4a/Arf and p21 to
increased efficiency of reprogramming in
Jmjd3-deficient MEFs, we knocked down
the expression of these genes with specific
shRNAs (Figure S2B). Although knock-
down of Jmjd3, Ink4a/Arf, or p21 alone by
shRNAs increased reprogramming effi-
ciency, compared to that in MEFs trans-
duced with a control shRNA, the efficiency
nearly doubled with simultaneous knock-
down of Jmjd3 and Ink4a/Arf or p21 (Fig-
ure 3D), suggesting that Jmjd3 might
have additional effects on reprogramming.To test this possibility, we generated Jmjd3-N (containing the
N-terminal 450 aa), Jmjd3-DJmjC (containing a deletion in the
catalytic Jumonji domain), and Jmjd3-H1390A (containing
a point mutation in the catalytic domain) constructs, all of which
lack the H3K27me3 demethylase activity toward H3K27 trime-
thylation (Figure S2C). To determine whether Jmjd3-mediated
inhibition of reprogramming depends upon expression of
Ink4a/Arf and p21, we showed that ectopic expression of full-
length Jmjd3, but not Jmjd3-N, Jmjd3-DJmjC, or Jmjd3-
H1390A, in Jmjd3-deficient MEFs restored the expression of
Ink4a/Arf (Figure 3E) andmarkedly inhibited reprogramming (Fig-
ure 3F). Surprisingly, two Jmjd3 mutants (Jmjd3-DJmjC and
Jmjd3-H1390A) that lacked H3K27 demethylase activity and
failed to upregulate Ink4a/Arf expression were still capable
of inhibiting reprogramming in Jmjd3-deficient MEFs (Fig-
ure 3F), suggesting that Jmjd3 can modulate reprogramming
through a previously unknown, demethylase activity-indepen-
dent pathway.
PHF20 Is a Key Target of the Jmjd3 Protein
To search for the targets of Jmjd3, we performed a comparative
analysis of microRNA (miRNA) and messenger RNA (mRNA)
gene expression between WT and Jmjd3-deficient MEFs but
failed to identify any gene that could be responsible for the
increased reprogramming efficiency in Jmjd3-deficient MEF
cells (data not shown). Hence, we turned our attention to the
expression levels of epigenetic factors because they are critical
in reprogramming somatic cells to an ESC-like state (Plath and
Lowry, 2011; Stadtfeld and Hochedlinger, 2010). By comparing
the expression of 59 genes that encode histone modification
proteins, we identified 18 genes that were markedly upregulated
at the RNA level in iPSCs/ESCs versus MEFs and 11 genes that
were upregulated between iPSCs/ESCs versus human fibro-
blasts (Figure S2D and S2E). Among them, seven genes were
highly expressed in both mouse and human (Figure S2F). Of
these, only PHF20 (also called GLEA2) showed a marked
increase of expression in Jmjd3-deficient MEFs, iPSCs, and
ESCs versus WT MEFs (Figure 3G). However, no appreciable
differences in PHF20 mRNA and H3K27 trimethylation were
observed between WT and Jmjd3-deficient MEFs (Figures S3A
and S3B). PHF20 was strongly expressed in testis, ovary, and
ES cells but was weakly expressed in other tissues (Figures
S3C and S3D). Interestingly, PHF20 expression gradually
increased in WT MEFs during reprogramming, which was
accelerated in Jmjd3-deficient MEFs (Figure 3H). These results
suggest that the PHF20 protein is an important target of Jmjd3
and thus may play a role in ESCs and iPSCs.
Requirement for PHF20 in the Maintenance and
Reprogramming of ESCs and iPSCs
Because the PHF20 protein is abundantly expressed in both
ESCs and iPSCs, we next sought to determine its importance
in the maintenance of these cell types. After knocking down
PHF20 in ESCs with specific shRNAs containing a green fluores-
cent protein (GFP) cassette (Figure S4A), ESCs underwent
differentiation, whereas ESCs transduced with control shRNA
remained undifferentiated (Figure 4A). Furthermore, RT-PCR
and western blot analyses revealed that PHF20 expression in
ESCs, like that of Oct4 and Nanog, was markedly reduced after
withdrawal of leukemia-inhibiting factor (LIF) and addition of
retinoic acid (RA) in the culture medium (Figures 4B and 4C).
Similar results were obtained with iPSCs (Figures S4B and
S4C). To determine whether stable ESC lines could be derived
from WT and PHF20 KO mice, we found that ESC lines
could be readily generated from WT mice, but not from PHF20
KO mice (Figures S4D and S4E). WT ESCs expressed AP,
Nanog, and Oct4 proteins, whereas cells from PHF20 KO
blastocysts did not (Figure S4E) and differentiated rapidly into
trophectoderm, based on downregulation ofOct4 and upregula-
tion of Cdx2 (Figure S4F). These results suggest that PHF20
is required for the generation and maintenance of both ESCs
and iPSCs.
To further define the role of PHF20 in iPSC generation, we first
knocked down the protein in Tet-O-4F MEFs at different timepoints and tested its ability to form iPSC colonies. Knockdown
of PHF20 in the early stages of reprogramming (i.e., at day
0 or 4) markedly blocked iPSC generation, whereas, in the inter-
mediate or later stages (day 10 or 12), it led to a decreased (but
still significant) inhibitory effect on the numbers of iPSC colonies
(Figure 4D). Using PHF20 KO MEFs (Figure 4E), we showed that
reprogramming to iPSCs with either 3F or 4F was significantly
inhibited in PHF20-deficient MEFs (Figure 4F), and the few
iPSC colonies that were generated from PHF20-deficient MEFs
showed only partially reprogrammed iPSCs (Figure 4G), sug-
gesting that PHF20 is required for the efficient generation of fully
reprogrammed iPSCs.
Like the results obtained with Jmjd3-deficient MEFs, we
found that Jmjd3 knockdown in human fibroblasts enhanced
reprogramming, whereas PHF20 knockdown blocked this
process (Figures S4G and S4H). To clarify how Jmjd3 and
PHF20 reciprocally regulate reprogramming, we generated
Jmjd3/PHF20 single- or double-KO MEFs and tested their
ability to regulate reprogramming. Both Jmjd3-deficient and
Jmjd3/PHF20 double-KO MEF cells grew faster than WT and
PHF20-deficient cells, but no appreciable difference was
observed in the growth between WT and PHF20-deficient
cells (Figure S4I). As expected, Jmjd3 deletion enhanced
reprogramming, but PHF20 ablation inhibited this process (Fig-
ure 4H). Remarkably, Jmjd3 deletion failed to improve reprog-
ramming in Jmjd3 and PHF20 double-KO MEFs (Figure 4H),
suggesting that the proliferative advantage of Jmjd3-deficient
MEFs cannot overcome the failure of reprogramming in
PHF20-deficient MEFs. Similar results were obtained when
either Ink4a or p21 was knocked down in PHF20-deficient
MEFs; that is, loss of each of these regulators increased
reprogramming in WT MEFs but failed to rescue defective
reprogramming in PHF20-deficient MEFs (Figure 4I). Ectopic
expression of PHF20, by contrast, restored reprogramming in
PHF20-deficient MEFs (Figure 4J), suggesting a requirement
for expression of this gene in both WT and Jmjd3-deficient
MEFs.
To further examine the ability of PHF20 expression to facilitate
reprogramming, we generated Tet-O-PHF20 MEFs from rtTA:
Tet-O-PHF20 transgenicmice and treated themwith Dox, result-
ing in increased expression of PHF20 compared with Dox-
treated rtTA-expressingWTMEFs (Figure 4K). More importantly,
we observed that Dox-induced expression of PHF20 in these
cells led to a marked increase in the efficiency of 4F-mediated
reprogramming, compared with Dox-treated rtTA-expressing
WT MEFs (Figure 4K). Furthermore, overexpression of PHF20
could reverse the Jmjd3-mediated inhibition of reprogramming
(Figure 4L). The increased reprogramming efficiency in Tet-O-
PHF20 MEFs was not due to cellular proliferative activity
because there was no appreciable difference in cell growth
between WT and Tet-O-PHF20 MEFs, with or without Dox treat-
ment (Figure S4J). Instead, Dox-induced expression of PHF20
markedly blocked downregulation of Oct4, Sox2, and Nanog
in iPSCs and thus their differentiation after LIF withdrawal
(Figures S4K and S4L). Nonetheless, PHF20 overexpression
could not substitute for any of the 4F (Figure S4M). These results
indicate an essential requirement for PHF20 in somatic cell
reprogramming.Cell 152, 1037–1050, February 28, 2013 ª2013 Elsevier Inc. 1041
Figure 4. PHF20 Is Essential for Mainte-
nance and Reprogramming of iPSCs
(A) Bright-field and GFP images of ESCs trans-
duced with PHF20-specific or control shRNA.
Scale bars, 50 mm.
(B) Real-time PCR analysis of PHF20, Oct4, and
Nanog expression in ESCs treated with 1 mM RA
and LIF withdrawal.
(C) Western blot analysis of PHF20, Oct4, and
Nanog expression after treatment of ESCs with
1 mM RA and LIF withdrawal.
(D) Colony formation after PHF20 knockdown by
PHF20-specific or a control lentivirus-based
constitutive shRNA at different time points (i.e.,
days 0, 4, 8, or 12) during reprogramming of Tet-O-
4F MEFs. AP-positive colonies were counted on
day 14.
(E) RT-PCR and western blot analyses of
PHF20 expression in WT and PHF20-deficient
MEFs.
(F) AP-positive colony numbers were counted on
day 14 of 4F-mediated or on day 21 of 3F-mediated
reprogramming of WT and PHF20-deficient MEFs.
(G) Bright-field images and AP staining of iPSC-like
colonies from WT and PHF20-deficient MEFs.
Scale bars, 50 mm.
(H) Number of AP-positive colonies counted on day
14 of 4F-mediated reprogramming of WT and
PHF20 single or Jmjd3 and PHF20 double-KO
MEFs.
(I) Number of AP-positive colonies on day 14 of 4F-
mediated reprogramming of WT and PHF20 KO
MEFs transduced with Ink4a/Arf- or p21-specific or
control shRNA.
(J) Number of AP-positive colonies counted on
day 14 of 4F-mediated reprogramming of WT and
PHF20 KO MEFs with or without PHF20 cDNA
expression.
(K) Western analysis of PHF20 expression in WT
and Tet-O-PHF20 transgenic MEFs expressing
rtTA in the presence of Dox. AP-positive colonies
were counted on day 14 of 4F-mediated re-
programming of rtTA-expressing Tet-O-PHF20
transgenic MEFs.
(L) Number of AP-positive colonies counted on day 14 of 4F-mediated reprogramming of WT MEFs transduced with Tet-O-Jmjd3 or Tet-O-PHF20 in the
presence of Dox until day 10.
The data in (D), (F), and (H)–(L) are plotted as means ± SD with indicated significance (*p < 0.05 and **p < 0.01). See also Figure S4.Jmjd3 Interacts with PHF20 and Mediates Its
Proteasomal Degradation
To dissect the molecular mechanisms by which Jmjd3 and
PHF20 reciprocally control reprogramming, we first showed their
localization in the nucleus by immunofluorescent staining and
fractionation of ESCs and iPSCs (Figures S5A and S5B). Coim-
munoprecipitation (co-IP) and western blot analyses of 293T
cells transfected with Flag-PHF20 and hemagglutinin (HA)-
Jmjd3 revealed that Jmjd3 interacted with PHF20 (Figure 5A).
Similar results were obtained with WT MEFs, but not with
PHF20-deficient MEFs (Figure 5B), suggesting that Jmjd3 inter-
acts with PHF20 under physiological conditions. We then per-
formed domain-mapping experiments with Jmjd3-N (1–450
aa), Jmjd3-M (400–1,200 aa), and Jmjd3-C (1,201–1,683 aa),
showing that the Jmjd3-N and Jmjd3-C constructs, but not
Jmjd3-M, interacted with PHF20 (Figure 5C). Similarly, the1042 Cell 152, 1037–1050, February 28, 2013 ª2013 Elsevier Inc.N-terminal region (1–332 aa containing a DNA-binding domain),
but not the C-terminal region, of PHF20 interacted with Jmjd3
(Figure 5D and Figure S5C). Further experiments showed that
Jmjd3, but not Utx or Uty, interacted with PHF20 (Figure S5D),
suggesting that Jmjd3 specifically interacts with PHF20 via their
functional domains.
What are the functional consequences of the Jmjd3-PHF20
interaction? To address this question, we transfected 293T cells
with a fixed amount of Flag-PHF20 together with increasing
amounts of HA-Jmjd3 and found that the amounts of PHF20
protein decreased with increasing expression of Jmjd3 protein
(Figure S5E). Similarly, the amounts of endogenous PHF20
protein were decreased in 293T cells transfected with increasing
amounts of Jmjd3 complementary DNA (cDNA) (Figure 5E).
Furthermore, the amount of endogenous PHF20 protein in
Jmjd3-deficient MEFs was much higher than in WT MEFs,
Figure 5. Jmjd3 Interacts with PHF20 and
Causes Its Degradation
(A) 293T cells were transfected with Flag-PHF20
and HA-Jmjd3. Cell extracts were immunoprecip-
itated with anti-Flag beads, followed by IB with an
anti-HA antibody. IB of whole-cell lysates (WCL)
without immunoprecipitation was used to detect
protein expression throughout experiments.
(B) Detection of interaction between Jmjd3 and
PHF20 in WT and PHF20 KO MEFs by IP with
a PHF20 antibody, followed by IB with an anti-
Jmjd3 antibody.
(C and D) 293T cells were transfected with different
HA-Jmjd3 domain constructs (C) and different
Flag-PHF20 constructs (D). Cell extracts were
immunoprecipitated with anti-Flag beads, fol-
lowed by IB with an anti-HA antibody.
(E) 293T cells were transfected with increasing
amounts of HA-Jmjd3 cDNA, followed by IB with
anti-PHF20 and anti-HA antibodies.
(F) Jmjd3 WT and KOMEF cells were infected with
or without Flag-tagged Jmjd3 retrovirus for 24 hr,
and cell extracts were analyzed by IB with anti-
PHF20 and anti-Jmjd3 antibodies.
See also Figure S5.whereas ectopic expression of Jmjd3 cDNA in Jmjd3-deficient
MEFs reduced the amount of PHF20 protein to a level similar
to that in WT MEFs (Figure 5F). It therefore appears that Jmjd3
negatively regulates PHF20 protein by targeting it for
degradation.
Trim26 Is an E3 Ubiquitin Ligase Required for
PHF20 Ubiquitination and Degradation
To determine how Jmjd3 causes the degradation of PHF20, we
first tested whether PHF20 is ubiquitinated in 293T cells trans-
fected with WT ubiquitin or ubiquitin mutants containing only
one lysine, at position 48 (K48) or 63 (K63). Immunoprecipitation
and immunoblot analyses revealed that PHF20 was strongly
ubiquitinated with ubiquitin mutant K48 but had little or no
K63-linked ubiquitination. Furthermore, such a K48-linked ubiq-
uitination was observed only when Jmjd3 and PHF20were coex-
pressed (Figure 6A), suggesting that Jmjd3 specifically targets
PHF20 for K48-linked polyubiquitination.
Because Jmjd3 is not an E3 ubiquitin ligase, we reasoned that
Jmjd3 might function as an adaptor to recruit an E3 ubiquitinCell 152, 1037–1050, Fligase to PHF20 for ubiquitination. To
test this prediction, we designed a screen
using 293T cells transfected with Jmjd3
expression vector and a lentivirus-based
shRNA sublibrary against human E3
ubiquitin ligases, as previously described
(Cui et al., 2012). In an initial screening of
about 600 shRNAs, we identified an E3
ubiquitin ligase (Trim26)-specific shRNA
that was associated with increased
PHF20 protein amounts, relative to results
with control shRNA (Figures S6A and
S6B). To substantiate this finding, weselected two shRNAs for human Trim26 and three for murine
Trim26, with 60%–90% knockdown efficiency (Figures S6C
and S6D). Knockdown of endogenous Trim26 by shRNAs
markedly abrogated Jmjd3-mediated ubiquitination of PHF20
in 293T cells (Figure 6B), with similar results obtainedwhen either
Jmjd3 or Trim26 was knocked down in PHF20+/+ MEFs (Fig-
ure S6E). Consistent with these results, we found that knock-
down of Trim26 increased reprogramming efficiency in PHF20
WTMEFs, but not in PHF20-deficient MEFs (Figure 6C). Further-
more, knockdown of Trim26 reversed Jmjd3-mediated inhibition
of reprogramming (Figure S6F), whereas overexpression of
Trim26 inhibited reprogramming efficiency enhanced by Jmjd3
knockdown (Figure S6G).
Because Trim26 and Jmjd3 could act in concert to modulate
reprogramming by targeting PHF20 for ubiquitination and
degradation, we next determined their expression patterns
during reprogramming and found that Trim26 was decreased,
whereas Jmjd3 was increased (Figure 6D). As expected,
PHF20 expression gradually increased, but PHF20 protein in
Jmjd3/ MEFs was significantly higher than that in WT cellsebruary 28, 2013 ª2013 Elsevier Inc. 1043
Figure 6. Jmjd3 Targets PHF20 for Ubiquiti-
nation by Recruiting an E3 Ligase, Trim26
(A) 293T cells were transfected with WT, K48, or
K63-linked ubiquitin, Flag-taggedPHF20, and HA-
tagged Jmjd3. Cell lysates were immunoprecipi-
tated with anti-Flag beads, followed by IB with an
anti-ubiquitin antibody.
(B) 293T cells transfected with Flag-tagged
PHF20, HA-tagged Jmjd3, and different Trim26
shRNA constructs as indicated. Cell lysates were
immunoprecipitated with anti-Flag beads and
analyzed with an anti-K48 ubiquitin.
(C) Number of AP-positive colonies counted on
day 14 of 4F-mediated reprogramming of WT and
PHF20-deficient MEFs transduced with Trim26-
specific or control shRNAs. Asterisks indicate
significant differences between groups (*p < 0.05,
**p < 0.01, and N.S.p > 0.05).
(D) Western blot analysis of Jmjd3, Trim26, and
PHF20 expression in WT and Jmjd3-deficient
MEFs during cellular reprogramming.
(E) 293T cells transfected with HA-Trim26, Flag-
PHF20, and HA-Jmjd3 as indicated. Cell lysates
were immunoprecipitated with anti-Flag beads,
followed by IB with an anti-K48 ubiquitin antibody.
(F) 293T cells transfected with Flag-Trim26, GFP-
PHF20, and HA-Jmjd3 as indicated. Cell lysates
were immunoprecipitated with anti-Flag beads,
followed by IB with PHF20 and HA antibodies.
(G) 293T cells transfected with Myc-Trim26 and
HA-Jmjd3 constructs. Cell lysates were immuno-
precipitated with anti-HA beads, followed by IB
with an anti-Myc antibody.
(H) 293T cells transfected with Flag-PHF20 and
HA-Jmjd3 constructs. Cell lysates were immuno-
precipitated with anti-Flag beads, followed by IB
with an anti-K48 ubiquitin antibody.
See also Figure S6.during reprogramming (Figures 6D andS6H). Although treatment
with the protease inhibitor MG132 blocked protein degradation
even when both Trim26 and Jmjd3 were overexpressed (Fig-
ure S6I), it was nonspecific and caused cell death. Thus, we
did not observe any iPSC colony formation after MG132 treat-
ment (Figure S6J).1044 Cell 152, 1037–1050, February 28, 2013 ª2013 Elsevier Inc.We then asked whether ectopic ex-
pression of Trim26 would promote
PHF20 ubiquitination and degradation.
Indeed, coexpression of Trim26 and
Jmjd3 led to a remarkable increase in
K48-linked ubiquitination and degrada-
tion of PHF20, compared with Trim26 or
Jmjd3 alone (Figure 6E). To determine
whether Trim26 interacts with Jmjd3 or
PHF20, we performed immunoprecipita-
tion experiments using cells that ex-
pressed Jmjd3 or PHF20 alone, three
double combinations, or Trim26, Jmjd3,
and PHF20 together. Although Trim26
interacted with Jmjd3, but not PHF20
(Figure 6F), we detected both Jmjd3 andPHF20 in the anti-Flag-Trim26 immunoprecipitates of the cells
that expressed Jmjd3, PHF20, and Trim26 (Figure 6F), suggest-
ing that Jmjd3 is an adaptor protein that recruits Trim26
to PHF20. To determine which domain of Jmjd3 is responsible
for recruiting Trim26 to PHF20, we transfected 293T cells
with Jmjd3-N, Jmjd3-M, or Jmjd3-C, together with Trim26.
Immunoprecipitation and western blot experiments revealed
that the N terminus of Jmjd3 (Jmjd3-N), but not Jmjd3-M and
Jmjd3-C, was capable of binding to Trim26 (Figure 6G). To iden-
tify the domain of Jmjd3 that is required for Trim26-mediated
ubiquitination of PHF20, we transfected 293T cells with Flag-
PHF20, together with HA-tagged Jmjd3-N, Jmjd3-M, Jmjd3-C,
Jmjd3-DJmjC, Jmjd3-H1390A, or full-length Jmjd3. After immu-
noprecipitation with anti-Flag, we assessed K48-linked ubiquiti-
nation of PHF20, observing that none of the Jmjd3-N, Jmjd3-M,
and Jmjd3-C constructs were sufficient to cause PHF20 ubiqui-
tination (Figure 6H). By contrast, like full-length Jmjd3, Jmjd3-
DJmjC and Jmjd3-H1390A were able to mediate PHF20 ubiqui-
tination (Figure 6H), which is consistent with results showing that
Jmjd3-DJmjC and Jmjd3-H1390A could still inhibit iPSC reprog-
ramming in Jmjd3-deficient MEFs (Figure 3F). These results
suggest that the N terminus of Jmjd3 (Jmjd3-N) can interact
with Trim26 but is not sufficient to cause PHF20 ubiquitination.
Either WT Jmjd3 or mutant Jmjd3 containing the first 1,200 aa
or a point mutation (Jmjd3-DJmjC or Jmjd3-H1390A) is neces-
sary and sufficient to target PHF20 for ubiquitination by recruit-
ing the E3 ligase Trim26.
PHF20 Is Required for Endogenous Oct4 Expression
and Interacts with Wdr5 during Reprogramming
Because PHF20 is essential for reprogramming in both WT and
Jmjd3-deficient MEFs, we reasoned that it might be required
for the reactivation of endogenous key genes such as Oct4
and other markers of ESCs. To test this prediction, we examined
the effects of PHF20 loss on the activation of 11 ESC markers
during Tet-O-4F reprogramming, using WT and PHF20/
MEFs in the presence of Dox for the first 10 days (followed by
withdrawal). Real-time PCR analysis on day 14 revealed that
expression of Oct4, Sox2, Nanog, Dnmt3l, Esg1, Eras, Rex1,
and Cripto could not be activated or substantially reduced in
PHF20-deficient MEFs but were highly activated in WT MEFs.
By contrast, Stat3, Grb2, and b-catenin were activated normally
in both WT and PHF20-deficient cells (Figure 7A). Notably, Sox2
and Nanog could be reactivated when Dox was retained during
reprogramming (Figure S7A). Overexpression of Oct4 or even
4F could not rescue the incompletely reprogrammed phenotype
of PHF20-deficient MEFs after reprogramming (Figure S7B),
suggesting that PHF20 is an upstream factor that controls
many key reprogramming and pluripotency factors.
Because reactivation of endogenous Oct4 is essential for the
generation of completely reprogrammed iPSCs (Ang et al.,
2011), we next determined whether PHF20 could directly bind
to the Oct4 promoter in vivo. Chromatin immunoprecipitation
(ChIP)-PCR assay revealed that PHF20 was strongly bound to
this promoter in WT ESCs and iPSCs, but not in PHF20-deficient
(differentiated) ESCs and (incompletely reprogrammed) iPSCs
(Figures 7B and 7C). PHF20 was unable to bind to the promoter
regions of Cripto, Dnmt3l, Esg1, Eras, Nanog, Rex1, or Sox2
(Figure S7C). Furthermore, the binding of PHF20 to the Oct4
promoter increased gradually over the course of reprogramming
(Figure 7D). To further determine whether overexpression of
PHF20 could promote expression of endogenous Oct4, we
treated both WT and Tet-O-PHF20 MEFs expressing rtTA with
Dox during 4F-mediated reprogramming. The expression levelof Oct4 was markedly increased in Dox-treated Tet-O-PHF20
MEFs, compared with Dox-treated rtTA-expressing WT MEFs
(Figure 7E), suggesting that PHF20 promotes endogenous
Oct4 gene expression during reprogramming.
Because the DNA methylation status of the Oct4 promoter
serves as an important marker of fully reprogrammed iPSCs
(Stadtfeld and Hochedlinger, 2010), we undertook bisulfate
sequencing analysis of ESCs and iPSCs generated from WT
MEFs, which showed robust DNA demethylation in the Oct4
promoter regions. By contrast, incompletely reprogrammed
iPSC colonies from PHF20-deficient MEFs retained their DNA
methylation pattern (Figure 7F). More importantly, we showed
that ectopic expression of PHF20 could rescue the incompletely
reprogrammed state of PHF20-deficient iPSCs and the methyla-
tion status of the Oct4 promoter, similar to results for WT iPSCs
(Figure 7F).
PHF20 is a component of mixed-lineage leukemia (MLL)
H3K34 methyltransferase complexes with the core components
MLL, ASH2L, WDR5, and RBBP5, as well as a component of the
H4K16 acetyltransferase MOF (males absent on the first, also
called MYST1 or KAT8) complex (Cai et al., 2010; Dou et al.,
2005; Wysocka et al., 2005). Importantly, Wdr5 is also a key
component shared by MLL H3K4 methyltransferase and the
H4K16 acetyltransferase MOF (Cai et al., 2010; Dou et al.,
2005; Wysocka et al., 2005). However, it is not known whether
PHF20 interacts with Wdr5 or other components of these two
complexes. Because PHF20 is upregulated and binds to the
Oct4 promoter during reprogramming, we predicted that
PHF20 might interact with Wdr5 to promote endogenous Oct4
expression during reprogramming. To test this possibility, we
transfected 293T cells with PHF20, together with Wdr5, MLL3,
Dpy-30, Ash2l, or RbBP5, all core components of the H3K4
methyltransferase complex (Trievel and Shilatifard, 2009).
PHF20 interacted with Wdr5, but not with other proteins tested
(Figures 7G and S7D). Endogenous interactions between
PHF20 and Wdr5 or RbBP5 (but not Ash2L) were observed in
iPSCs (Figure 7H). ChIP-seq analysis of ESCs and iPSCs
confirmed that both PHF20 and Wdr5 were bound to the Oct4
promoter (Figure S7E). Among 6,209 genes bound by PHF20
and 7,774 genes bound by Wdr5, 2,348 genes were co-occu-
pied by PHF20 and Wdr5 in ESCs (Figure S7F and Table S3). In
determining the PHF20 and Wdr5 binding distribution relative to
gene structure (i.e., 50 distal, 50 proximal, 50 UTR, coding, intron,
30 UTR, 30 proximal, and 30 distal regions), we found that the
majority of PHF20 and Wdr5 binding sites were mapped to the
gene body (coding and intron regions) and 50 proximal region
in ESCs (Figure S7G). The distribution of PHF20 was more
pronounced toward the 50 end of genes with 9.7% of peaks at
the 50 proximal region, compared to 2.8% at the 30 proximal
region (Figure S7G). Consistent with this, we found that both
PHF20 and Wdr5 binding peaks centered on the transcriptional
start site (TSS) within a 7 kb region (from 2 to +5 kb) (Fig-
ure S7H). To determine the functional relevance of target genes
bound by PHF20 or by PHF20 and Wdr5, we performed gene
ontology (GO) analysis and found that binding targets were
enriched for genes involved in cell and organ developmental
processes, embryonic development, and cell differentiation
(Figure S7I).Cell 152, 1037–1050, February 28, 2013 ª2013 Elsevier Inc. 1045
Figure 7. PHF20 Is Required for Oct4 Expression during Reprogramming by Interacting with Wdr5
(A) WT and PHF20 KOMEFs were reprogrammed by 4F in the presence of Dox for 10 days, followed by Dox withdrawal. Real-time PCR analysis of endogenous
Oct4, Sox2, Nanog, and other ES genes was performed on day 14.
(B) Schematic diagram of Oct4 promoter regions.
(legend continued on next page)
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To determine whether PHF20 interacts with MOF, we per-
formed co-IP with anti-PHF20 and found that PHF20 interacted
with endogenous MOF in iPSCs (Figure 7H), which is consistent
with the results of a recent report showing that H3K4methylation
is closely associated with H4K16 acetylation (Wang et al.,
2009). Thus, PHF20 interacts with Wdr5 and MOF to bring the
H3K4 methyltransferase and H4K16 acetyltransferase MOF
complexes together. To understand how the loss of PHF20
results in failure to reactivate endogenous Oct4 expression, we
tested the possibility that PHF20 might affect the ability of
Wdr5, RbBP5, and MOF to bind to the Oct4 promoter region.
In ChIP-qPCR experiments with WT and PHF20-deficient cells,
Wdr5 failed to bind to theOct4 promoter in PHF20-deficient cells
but bound strongly to the Oct4 promoter in WT cells (Figure 7I).
Similarly, the ability of RbBP5 and MOF to bind to the Oct4
promoter was markedly reduced in PHF20-deficient cells.
Consistent with these results, ChIP-qPCR experiments revealed
a sharp reduction in H3K4 trimethylation at the Oct4 promoter,
whereas H4K16 acetylation was also affected but to a lesser
extent (Figure 7J). Taken together, these results suggest that
binding of PHF20 to the Oct4 promoter may be required for re-
cruiting the H3K4 methyltransferase complex and perhaps the
H4K16 acetyltransferase complex to bind to the same promoter
through the interaction with Wdr5 and MOF, leading to reactiva-
tion of endogenous Oct4 expression during reprogramming.
DISCUSSION
Using a shRNA knockdown screen in Tet-O-4F MEFs, we iden-
tified a number of histone-modifying proteins that are required
for the reprogramming of somatic cells to iPSCs, but only one,
Jmjd3, functions as a negative regulator of this process. Given
the sequential multistep nature of iPSC generation (Plath and
Lowry, 2011), it is not surprising that negative regulators of
reprogramming exist. Indeed, DOT1L was recently shown to
negatively control Nanog and LIN28 expression, posing an unex-
pected barrier to efficient reprogramming (Onder et al., 2012).
Until the full spectrum of such regulators is delineated and their
mechanisms of action deciphered, it will be difficult to revise
current approaches to iPSC generation with any degree of
confidence.(C) Determination of PHF20 binding to the CR regions of Oct4 promoter in iPSC
reported as fold enrichment relative to input DNA.
(D) ChIP-PCR analysis of timing of PHF20 binding to the Oct4 promoter region d
(E) Real-time PCR analysis of Oct4 expression in rtTA-expressing WT and Tet-O
(F) Bisulfite sequencing of the Oct4 promoter region in ESCs, PHF20+/+ MEF
programmed) cells from PHF20/ MEFs, and iPSCs from PHF20-expressing P
whereas closed circles (C) represent methylated CpGs.
(G) 293T cells were transfected with GFP-PHF20, Flag-tagged Wdr5, MLL3, Dp
beads, followed by IB with an anti-PHF20 antibody.
(H) Detection of endogenous interaction between PHF20 andWdr5 complexes in i
Ash2L antibodies.
(I) ChIP-qPCR analysis of Wdr5, RbBP5, and MOF binding to Oct4 promoter reg
(J) ChIP-qPCR analysis of H3K4me3 and H4K16ac mark of the Oct4 promoter in
reprogrammed) cells.
(K) Proposed working model by which Jmjd3 regulates somatic cell reprogramm
The data in (A), (C)–(E), (I), and (J) are plotted as means ± SD with indicated sign
Table S3.Jmjd3 plays a critical role in the upregulation of Ink4a/Arf by
modulating the levels of H3K27 trimethylation in the promoter
(Agger et al., 2009; Barradas et al., 2009). These effects on the
expression of Ink4a/Arf and p21, in turn, induce senescence
and inhibit reprogramming (Hong et al., 2009; Kawamura et al.,
2009; Li et al., 2009; Mario´n et al., 2009; Utikal et al., 2009), which
is consistent with our demonstration that Jmjd3 ablation reduces
cell senescence and promotes reprogramming of Jmjd3-defi-
cient MEFs. However, we provide several lines of evidence
indicating that Jmjd3 can regulate reprogramming through
a previously unrecognized, histone demethylase activity-inde-
pendent pathway. First, the combined knockdown of Jmjd3
with Ink4a or p21 resulted in significantly more iPSC colonies
than did knockdown of any single gene alone. Second, although
ectopic expression of full-length Jmjd3 in Jmjd3-deficient
MEFs restored Ink4a/Arf expression and strongly inhibited
the efficiency of reprogramming, the Jmjd3 mutants Jmjd3-
DJmjC and Jmjd3-H1390A, defined by their lack of H3K27me3
demethylase activity and inability to upregulate Ink4a/Arf
expression, could still inhibit reprogramming in Jmjd3-deficient
MEFs. We therefore propose that Jmjd3 exploits both demethy-
lase activity-dependent and -independent mechanisms to regu-
late somatic cell reprogramming, with the latter having a predom-
inant role.
An extensive search for target molecules that might be
involved in a Jmjd3-mediated but demethylase activity-indepen-
dent pathway led to the identification of PHF20. We provide
evidence of a critical role for PHF20 expression in the mainte-
nance of the pluripotent state. PHF20 was first identified as an
antibody-reactive protein that is highly expressed in several
types of cancer (Fischer et al., 2001; Wang et al., 2002).
PHF20 has since been identified as a histone code reader that
specifically recognizes the dimethylation of H3K4, H3K9,
H4K20, and H4K79 (Adams-Cioaba et al., 2012; Kim et al.,
2006). Recent studies show that it also regulates p53 at both
the transcriptional and posttranscriptional levels in response to
DNA damage (Li et al., 2013; Park et al., 2012). Mice with
PHF20 ablation die shortly after birth (Badeaux et al., 2012).
Consistently, we failed to generate ESC lines from PHF20 KO
mice. PHF20 deficiency almost completely inhibits reprogram-
ming of PHF20-deficient MEFs, suggesting an absolutes and ESCs by ChIP-qPCR analysis with PHF20-specific antibody. Values are
uring 4F-mediated reprogramming using a PHF20-specific antibody.
-PHF20 transgenic MEFs during reprogramming.
s, PHF20/ MEFs, iPSCs from PHF20+/+ MEFs, iPS-like (incompletely re-
HF20/ MEFs. Open circles (B) represent unmethylated CpG dinucleotides,
y-30, Ash2L, or Rbbp5. Cell extracts were immunoprecipitated with anti-Flag
PSCs by IPwith a PHF20 antibody, followed by IBwithWdr5, RbBP5,MOF, and
ion during 4F-mediated reprogramming of WT and PHF20-deficient MEFs.
WT MEF-derived iPSCs and PHF20-deficient derived iPSC-like (incompletely
ing.
ificance (*p < 0.05 and **p < 0.01 by Student’s t test). See also Figure S7 and
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requirement for this factor in iPSC reprogramming and genera-
tion of ESCs.
Jmjd3 has been shown to play an important role in T cell
lineage commitment by interacting with T-bet and Brg1 in a
demethylase activity-independent manner (Miller et al., 2010).
Here, we show that Jmjd3 interacts with PHF20, targeting it for
ubiquitination and proteasomal degradation. Although both the
N- and C-terminal regions of Jmjd3 protein can bind to the N
terminus of PHF20, Jmjd3 itself cannot ubiquitinate PHF20.
Instead, it recruits an E3 ligase, Trim26, to PHF20 for K48-linked
polyubiquitination. Indeed, knockdown of Trim26 abolishes
PHF20 ubiquitination and degradation, thus enhancing iPSC
reprogramming. Further experiments demonstrated that, like
full-length Jmjd3, certain Jmjd3 mutants (Jmjd3-DJmjC and
Jmjd3-H1390A), but not Jmjd3-N, Jmjd3-M, or Jmjd3-C, target
PHF20 for ubiquitination. These results emphasize the impor-
tance of Jmjd3-Trim26-mediated ubiquitination in the negative
regulation of reprogramming.
Fully reprogrammed iPSCs are accompanied by changes in
distinct DNA methylation patterns associated with reactivation
of endogenous Oct4 and several other ESC marker genes (Plath
and Lowry, 2011; Stadtfeld and Hochedlinger, 2010). How, then,
does PHF20 deficiency lead to failure to reactivate these endog-
enous marker genes, thus imposing amajor barrier to successful
reprogramming? A recent study shows that exogenous Oct4,
together with other key reprogramming factors, first induces
Wdr5 expression in MEFs, which, in turn, promotes formation
of a Wdr5-Oct4 complex that binds to the Oct4 promoter,
leading to reactivation of endogenous Oct4 expression (Ang
et al., 2011). To directly link PHF20 to Oct4 expression, we
show that PHF20 not only binds to the Oct4 promoter region
but also specifically interacts with Wdr5 and MOF. A recent
study shows thatMOF is required for ESC self-renewal and func-
tion and regulates Nanog expression (Li et al., 2012). Deletion of
PHF20 reduces the ability of Wdr5 and MOF to bind to the Oct4
promoter, suggesting a critical requirement for this protein in
reactivation of endogenous Oct4 expression and, hence, for
successful generation of fully reprogrammed iPSCs. Consistent
with this notion, our results further demonstrated that PHF20
deficiency results in failure to reactivate expression of many
endogenous ESC marker genes during reprogramming, sug-
gesting that PHF20 affects expression of many key ESC genes
directly or indirectly. ChIP-qPCR and ChIP-seq analyses show
that PHF20 and Wdr5 bind to the Oct4 promoter, but not to the
promoter regions of Sox2, Nanog, Dnmt3l, Esg1, Eras, Rex1,
and Cripto. In addition, ChIP-seq analysis revealed that both
PHF20 and Wdr5 bind to several key epigenetic factor genes,
including Baf155, Brg1, and Sall4. Hence, these findings
explain why the incompletely reprogrammed phenotype of
PHF20-deficient MEFs cannot be rescued by overexpression
of Oct4 or 4F (OSKM) and further suggest that PHF20 functions
as an upstream regulator that controlsOct4 and many other crit-
ical ESC marker genes, thus providing a mechanistic link
between Jmjd3-mediated PHF20 degradation and deficient
reprogramming.
On the basis of these findings, we propose a working model to
explain how the Jmjd3-PHF20 axis regulates iPSC reprogram-
ming. Increased expression of Jmjd3 due to 4F-mediated re-1048 Cell 152, 1037–1050, February 28, 2013 ª2013 Elsevier Inc.programming inWTMEFs initiates at least two distinct pathways
(Figure 7K): (1) Jmjd3 upregulates Ink4a/Arf and p21 by modu-
lating H3K4 and H3K27 methylation through its H3K27me2/3
demethylase activity. Increased amounts of Ink4a, Arf, and p21
induce cell senescence or apoptosis and reduce cell prolifera-
tion, thus decreasing the efficiency and kinetics of reprogram-
ming. (2) Jmjd3 protein also targets PHF20 for ubiquitination
and degradation by recruiting an E3 ligase, Trim26, in an
H3K27 demethylase activity-independent manner. The resultant
decrease in PHF20 protein leads to the loss or negligible
expression of endogenous Oct4, thereby greatly reducing
reprogramming efficiency. We conclude that the demethylase
activity-dependent and -independent pathways used by Jmjd3
act in concert to potently restrain the kinetics and efficiency of
reprogramming. The observations that Jmjd3 loss reduces cell
senescence and apoptosis and increases cell proliferation and
that increased amounts of PHF20 lead to reactivation of endog-
enous Oct4 expression suggest means to enhance the outcome
of somatic cell reprogramming overall.
EXPERIMENTAL PROCEDURES
Mice
Tet-O-Sox2 and -Klf4 transgenic mice were generated and crossed with
Rosa-rtTA, Tet-O-Oct4 (from the Jackson Laboratories), and Tet-O-Myc trans-
genic mice. Tet-O-4F MEFs that express rtTA and Tet-O-Oct4, Sox2, Klf4, and
Myc were established and used for reprogramming. Tet-O-PHF20 mice were
generated as Tet-O-Sox2 and -Klf4 transgenic mice. Jmjd3 was deleted at
exons 15–21 using a Cre-LoxP system. Jmjd3 was globally deleted by
crossing Jmjd3f/f mice with Hprt-Cre mice (Jackson Laboratories).
Generation of iPSCs from MEFs and Tet-O-4F MEFs
Mouse iPSCs were generated from MEFs, as previously described (Takahashi
et al., 2007a), with some minor modifications. Tet-O-4F MEFs were used to
generate iPSCs by treating MEFs with Dox in mESC medium. The efficiency
of iPSC formation was calculated based on the number of AP+ iPSC colonies
and the initial cell number of seeded MEFs. Human iPSCs were generated as
previously described (Park et al., 2008). Lentiviral particles were generated and
concentrated as previously described (Peng et al., 2005).
Screening for Epigenetic Factors that Modulate Reprogramming
Efficiency
Tet-O-4F transgenic MEF cells (M2-11) were transduced with lentivirus-based
shRNAs specific for 15 epigenetic factors and then reseeded on irradiated
feeder cells at the desired density. The next day, mESC medium containing
2 mg/ml Dox was added and replenished every day. The colonies were stained
for AP activity on days 12–14.
Co-IP, ChIP-PCR, and ChIP-Seq Analysis
The cells were lysed in RIPA buffer and analyzed as previously described (Cui
et al., 2010). ChIP assay was performed with Imprint Ultra Chromatin Immuno-
precipitation kit (Sigma). ChIP-seq libraries were prepared, sequenced, and
analyzed. See Extended Experimental Procedures for details.
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